Atlas Trials

Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying

Clinical trial NCT01910194 · COMPLETED

Trial details

NCT number
NCT01910194
Sponsor
Profil Institut für Stoffwechselforschung GmbH
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2013-12-01
Primary completion
2014-10-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.